Number of Hours of Sleep and Risk of Stroke

Sleep duration (either short or long) affect the risk of stroke according to this recent analysis. We had visited a study published in JACC on the link between acute MI and sleep duration. This study appears to show similar results as regards sleep duration and stroke. 

Cantidad de horas de sueño y riesgo de stroke

The work prospectively included 79,881 men and women between 45 and 79 followed up until their first event (event or stroke) for mean 14.6 years. The study also looked into genetic polymorphisms identified with sleep duration obtained from a publicly available database (MEGASTROKE and the International Stroke Genetics Consortia).

Long sleep (>9 hours a day) was associated with increased total risk of stroke and ischemic stroke (HR 1.12 and 1.14, respectively), while short sleep (<7 hours a day) increased the risk of intracranial bleeding. 

These results replicate almost exactly the MI results, where sleeping over 9 hours a day or fewer than 6 hours a day increases MI risk by 20 to 30%.


Read also: Hours of Sleep and Myocardial Infarction Risk.


The genetic analysis was not that clear, opening the possibility of a casual association. Without question, we do not have enough information to recommend a number of hours of sleep a day as primary prevention strategy against MI or stroke.

Conclusion

This large prospective study associated long sleep with increased risk of total and ischemic stroke, while short sleep was associated to intracranial bleeding. 

Original Title: Sleep Duration and Stroke. Prospective Cohort Study and Mendelian Randomization Analysis.

Reference: Olga E. Titova et al. Stroke. 2020 Nov;51(11):3279-3285. doi: 10.1161/STROKEAHA.120.029902.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Transcatheter Pulmonary Valve Implantation with a Self-Expanding Valve: Outcomes at 3 Years

Pulmonary regurgitation (PR) is a common condition in patients who have undergone surgical repair of Tetralogy of Fallot or other pathologies involving the right...

RACE Trial: Effect of Balloon Pulmonary Angioplasty and Riociguat on Right Ventricular Afterload and Function in Chronic Thromboembolic Pulmonary Hypertension

Even though pulmonary endarterectomy is the treatment of choice for chronic thromboembolic pulmonary hypertension (CTEPH), up to 40% of patients are not candidates because...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...